PKPaturu Kondaiah

Paturu Kondaiah

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Paturu Kondaiah has a total of 129 co-authors. Here are the top co-authors by number of shared publications:

  • Akhil R. Chakravarty

    Department of Inorganic and Physical Chemistry, Indian Institute of Science, Bangalore 560012, India

    24 shared publications
  • Imran Khan

    Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore, India

    14 shared publications
  • Ila Pant

    Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Sir C.V. Raman Avenue, Bangalore 560 012, India

    12 shared publications
  • Koushambi Mitra

    Department of Inorganic and Physical Chemistry and ‡Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science , Bangalore 560012, India

    9 shared publications
  • Akhtar Hussain

    †Department of Inorganic and Physical Chemistry and ‡Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore 560012, Karnataka, India

    8 shared publications
  • Uttara Basu

    Department of Chemistry Birla Institute of Technology & Science Pilani K K Birla Goa Campus, NH 17 B, Zuarinagar Goa 403 726 India

    7 shared publications

Latest Publications

  • Open Access

    In vitro characterization of CD133lo cancer stem cells in Retinoblastoma Y79 cell line

    by Rohini M. Nair, Murali Ms. Balla, Imran Khan, Ravi Kiran Reddy Kalathur, Paturu Kondaiah, Geeta K. Vemuganti

    Retinoblastoma (Rb), the most common childhood intraocular malignant tumor, is reported to have cancer stem cells (CSCs) similar to other tumors. Our previous investigation in primary tumors identified the small sized cells with low CD133 (Prominin-1) and high CD44 (Hyaluronic acid receptor) expression to be putative Rb CSCs using flow cytometry (FSClo/SSClo/CD133lo/CD44hi). With this preliminary data, we have now utilized a comprehensive approach of in vitro characterization of Y79 Rb cell line following CSC enrichment using CD133 surface marker and subsequent validation to confirm the functional properties of CSCs. The cultured Rb Y79 cells were evaluated for surface markers by flow cytometry and CD133 sorted cells (CD133lo/CD133hi) were compared for CSC characteristics by size/percentage, cell cycle assay, colony formation assay, differentiation, Matrigel transwell invasion assay, cytotoxicity assay, gene expression using microarray and validation by semi-quantitative PCR. Rb Y79 cell line shared the profile (CD133, CD90, CXCR4 and ABCB1) of primary tumors except for CD44 expression. The CD133lo cells (16.1 ± 0.2%) were FSClo/SSClo, predominantly within the G0/G1 phase, formed larger and higher number of colonies with ability to differentiate to CD133hi cells, exhibited increased invasive potential in a matrigel transwell assay (p < 0.05) and were resistant to Carboplatin treatment (p < 0.001) as compared to CD133hi cells. The CD133lo cells showed higher expression of several embryonic stem cell genes (HOXB2, HOXA9, SALL1, NANOG, OCT4, LEFTY), stem cells/progenitor genes (MSI2, BMI1, PROX1, ABCB1, ABCB5, ABCG2), and metastasis related gene- MACC1, when compared to the CD133hi cells. This study validates the observation from our earlier primary tumor study that CSC properties in Rb Y79 cell line are endowed within the CD133lo population, evident by their characteristics- i.e. small sized, dormant in nature, increased colony forming ability, differentiation to CD133hi cells, higher invasiveness potential, drug resistance and primitive gene expression pattern. These findings provide a proof of concept for methodological characterization of the retinoblastoma CSCs with future implications for improved diagnostic and treatment strategies.


  • Curcumin “Drug” Stabilized in Oxidovanadium(IV)-BODIPY Conjugates for Mitochondria-Targeted Photocytotoxicity

    by Utso Bhattacharyya, Brijesh Kumar, Aditya Garai, Arnab Bhattacharyya, Arun Kumar, Samya Banerjee, Paturu Kondaiah, Akhil R. Chakravarty

    Ternary oxidovanadium(IV) complexes of curcumin (Hcur), dipicolylamine (dpa) base, and its derivatives having pendant noniodinated and di-iodinated boron-dipyrromethene (BODIPY) moiety (L1 and L2, respectively), namely, [VO(dpa)(cur)]ClO4 (1), [VO(L1)(cur)]ClO4 (2), and [VO(L2)(cur)]ClO4 (3) and their chloride salts (1a–3a) were prepared, characterized, and studied for anticancer activity. The chloride salts were used for biological studies due to their aqueous solubility. Complex 1 was structurally characterized by single-crystal X-ray crystallography. The complex has a VO2+ moiety bound to dpa ligand showing N,N,N-coordination in a facial mode, and curcumin is bound in its mono-anionic enolic form. The V–O(cur) distances are 1.950(18) and 1.977(16) Å, while the V–N bond lengths are 2.090(2), 2.130(2), and 2.290(2) Å. The bond trans to V═O is long due to trans effect. The complexes are stable in a solution phase over a long period of time of 48 h without showing any apparent degradation of the curcumin ligand. The diiodo-BODIPY ligand (L2) or Hcur alone showed limited solution stability in dark. The emissive BODIPY (L1) containing complex 2a showed preferential mitochondrial localization in MCF-7 cells in cellular imaging experiments. The cytotoxicity of the complexes was studied by MTT assay. The BODIPY complex 3a showed excellent photodynamic therapy effect in visible light (400–700 nm) giving IC50 values of 2–6 μM in HeLa and MCF-7 cancer cells, while being less toxic in dark (∼100 μM). The cell death was apoptotic in nature involving reactive oxygen species (ROS). Mechanistic data from pUC19 DNA photocleavage studies revealed photogenerated ROS as primarily 1O2 from the BODIPY moiety and ·OH radicals from the curcumin ligand.


  • Terpyridyl oxovanadium(IV) complexes for DNA crosslinking and mito-targeted photocytotoxicity

    by Arun Kumar, Ila Pant, Akanksha Dixit, Samya Banerjee, Bhabatosh Banik, Rupak Saha, Paturu Kondaiah, Akhil R. Chakravarty


  • Monofunctional BODIPY-Appended Imidazoplatin for Cellular Imaging and Mitochondria-Targeted Photocytotoxicity

    by Kausar Raza, Srishti Gautam, Aditya Garai, Koushambi Mitra, Paturu Kondaiah, Akhil R. Chakravarty

    Monofunctional platinum(II) complexes of formulation cis-[Pt(NH3)2(L)Cl](NO3), where L is an imidazole base conjugated to 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene (BODIPY) with emissive (L1 in 1) and nonemissive (L2 in 2) moieties were prepared and characterized, and their singlet oxygen-mediated photoinduced cytotoxicity was studied. The 1-methylimidazole (1-MeIm) complex 3 was prepared as a control and for structural characterization by X-ray crystallography. Complexes 1 and 2 showed strong visible absorption bands at 500 nm (ε = 2.7 × 104 M–1 cm–1) and 540 nm (1.4 × 104 M–1 cm–1). Complex 1 is emissive with a band at 510 nm (ΦF = 0.09) in 1% dimethyl sulfoxide/Dulbecco’s Modified Eagle’s Medium (pH 7.2). Singlet oxygen generation upon photoirradiation with visible light (400–700 nm) was evidenced from 1,3-diphenylisobenzofuran titration experiments showing significant photosensitizing ability of the BODIPY complexes. Both 1 and 2 were remarkably photocytotoxic in visible light (400–700 nm, 10 J cm–2) in skin keratinocyte HaCaT and breast cancer MCF-7 cells giving IC50 values in nanomolar concentration. The complexes were, however, essentially nontoxic to the cells in the dark (IC50 > 80 μM). Complex 2 having a diiodo-BODIPY unit is nonemissive but an efficient photosensitizer with high singlet oxygen generation ability in visible light (400–700 nm). Confocal microscopy using the emissive complex 1 showed significant mitochondrial localization of the complex. Cell death via apoptotic pathway was observed from the Annexin-V-FITC/PI assay. The formation of Pt-DNA adducts was evidenced from the binding experiments of the complexes 1 and 2 with 9-ethylguanine as a model nucleobase from 1H NMR and mass spectral studies.


  • Open Access

    Expression of tripartite motif-containing protein 28 in primary breast carcinoma predicts metastasis and is involved in the stemness, chemoresistance, and tumor growth

    by Surekha Damineni, Sai A Balaji, Abhijith Shettar, Swetha Nayanala, Neeraj Kumar, Banavathy S Kruthika, Kalyanasundaram Subramanian, M Vijayakumar, Geetashree Mukherjee, Vaijayanti Gupta, et al.

    The prediction of who develops metastasis has been the most difficult aspect in the management of breast cancer patients. The lymph node metastasis has been the most useful predictor of prognosis and patient management. However, a good proportion of patients with lymph node positivity remain disease free for 5 years or more, while about a third of those who were lymph node negative develop distant metastasis within the same period. This warrants a robust biomarker(s), preferably gene expression based. In order to elucidate gene-based biomarkers for prognosis of breast cancers, gene expression profiling of primary tumors and follow-up for over 5 years has been performed. The analysis revealed a network of genes centered around the tripartite motif-containing protein 28 as an important indicator of disease progression. Short hairpin RNA–mediated knockdown of tripartite motif-containing protein 28 in breast cancer cells revealed a decreased expression of epithelial-to-mesenchymal transition markers and increased expression of epithelial markers, decreased migration and invasion, and increased chemosensitivity to doxorubicin, 5-fluorouracil, and methotrexate. Furthermore, knockdown of tripartite motif-containing protein 28 resulted in the decrease of stemness as revealed by sphere formation assay as well as decreased expression of CD44 and Bmi1. Moreover, tripartite motif-containing protein 28 knockdown significantly reduced the tumor size and lung metastasis in orthotopic tumor xenograft assay in immunocompromised mice. The tumor size was further reduced when these mice were treated with doxorubicin. These data provide evidence for tripartite motif-containing protein 28 as a biomarker and a potential therapeutic target for breast cancer.


  • Self-Assembly of Discrete RuII8Molecular Cages and Their in Vitro Anticancer Activity

    by Aderonke Ajibola Adeyemo, Abhijith Shettar, Imtiyaz Ahmad Bhat, Paturu Kondaiah, Partha Sarathi Mukherjee

    Four new octanuclear Ru(II) cages (OC-1–OC-4) were synthesized from dinuclear p-cymene ruthenium(II) acceptors [Ru2(μ–η4-C2O4)(CH3OH)2(η6-p-cymene)2](O3SCF3)2 (A1), [Ru2(μ–η4-C6H2O4)(CH3OH)2(η6-p-cymene)2](O3SCF3)2 (A2), [Ru2(dhnq)(H2O)2(η6-p-cymene)2](O3SCF3)2 (A3), and [Ru2(dhtq)(H2O)2(η6-p-cymene)2](O3SCF3)2 (A4) separately with a tetradentate pyridyl ligand (L1) in methanol using coordination-driven self-assembly [L1= N,N,N′,N′-tetra(pyridin-4-yl)benzene-1,4-diamine]. The octanuclear cages are fully characterized by various spectroscopic techniques including single-crystal X-ray diffraction analysis of OC-4. The self-assembled cages show strong in vitro anticancer activity against human lung adenocarcinoma A549 and human cervical cancer HeLa cell lines as observed from the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay. Of all the octanuclear cages, OC-3 exhibits remarkable anticancer activity against both cancer cell lines and is more active than that reported for cisplatin. The excellent anticancer activity of OC-3 and OC-4 highlights the importance of the synergistic effects of the spacer component of the dinuclear p-cymene Ru(II) acceptor clips.


  • Platinum(II) Complexes of Curcumin Showing Photocytotoxicity in Visible Light

    by Koushambi Mitra, Srishti Gautam, Paturu Kondaiah, Akhil R. Chakravarty

    Three platinum(II) complexes of curcumin, [Pt(NH3)2(cur)](NO3) (1), [Pt(en)(cur)](NO3) (2) and [Pt(dach)(cur)](NO3) (3), where Hcur is curcumin, en is ethylenediamine and dach is 1R,2R‐(–)‐1,2‐diaminocyclohexane, were synthesized, characterized and their photocytotoxic properties were explored. The acetylacetone (Hacac) analogue of 1, [Pt(NH3)2(acac)]NO3 (4), was prepared to investigate the role of photoactive curcumin. The crystal structure of [Pt(NH3)2(acac)]CF3SO3 (4a) revealed square‐planar geometry of the platinum(II) centre. Complexes 1–3 displayed an intense absorption band at 450 nm (ε = 22500 m–1 cm–1). The curcumin in metal‐bound form showed improved stability in 10 % DMSO/buffer solution at 37 °C. The complexes released curcumin upon irradiation with visible light (400–700 nm) as evident from the increment in emission intensity. The complexes formed Pt–DNA covalent adducts when treated with calf thymus (ct)‐DNA and exposed to light. The platinum–curcumin conjugates demonstrated photocytotoxicity in cancer cells giving IC50 values of 15–45 µm (400–700 nm, 10 J cm–2) with no apparent activity in the dark (IC50 > 200 µm). Cytoplasmic localization and reactive oxygen species (ROS)‐mediated apoptotic cell death in visible light was observed for the curcumin complexes.


  • Open Access

    Role of areca nut induced JNK/ATF2/Jun axis in the activation of TGF-β pathway in precancerous Oral Submucous Fibrosis

    by Ila Pant, S. Girish Rao, Paturu Kondaiah

    Oral submucous fibrosis (OSF) is potentially premalignant with progressive and irreversible extracellular matrix deposition accompanied by epithelial atrophy and like other fibrotic disorders, is primarily a TGF-β driven disease. OSF is caused by prolonged chewing of areca nut. Our previous studies reported a pivotal role for TGF-β activation and its effects contributing to OSF. However, the mechanism for activation of TGF-β signaling in OSF is still unknown. In this study we demonstrate activation of TGF-β signaling with sub-cytotoxic dose of areca nut in epithelial cells and discovered a key role for pJNK in this process. In good correlation; pJNK was detected in OSF tissues but not in normal tissues. Moreover, activation of JNK was found to be dependent on muscarinic acid receptor induced Ca2+/CAMKII as well as ROS. JNK dependent phosphorylation of ATF2/c-Jun transcription factors resulted in TGF-β transcription and its signaling. pATF2/p-c-Jun were enriched on TGF-β promoter and co-localized in nuclei of epithelial cells upon areca nut treatment. In corroboration, OSF tissue sections also had nuclear pATF2 and p-c-Jun. Our results provide comprehensive mechanistic details of TGF-β signaling induced by etiological agent areca nut in the manifestation of fibrosis which can lead to new therapeutic modalities for OSF.


  • Photoactive platinum( ii ) β-diketonates as dual action anticancer agents

    by Md Kausar Raza, Koushambi Mitra, Abhijith Shettar, Uttara Basu, Paturu Kondaiah, Akhil R. Chakravarty

    Cyclometallated platinum( ii ) β-diketonates show significant photocytotoxicity in skin-keratinocyte HaCaT cells [IC 50 : ∼10 μM (visible light, 400–700 nm), ≥60 μM (dark)].


  • BODIPY‐Appended 2‐(2‐Pyridyl)benzimidazole Platinum(II) Catecholates for Mitochondria‐Targeted Photocytotoxicity

    by Koushambi Mitra, Srishti Gautam, Paturu Kondaiah, Akhil R. Chakravarty

    Platinum(II) complexes of the type [Pt(L)(cat)] (1 and 2), in which H2cat is catechol and L represents two 2‐(2‐pyridyl)benzimidazole ligands with 4,4‐difluoro‐4‐bora‐3a,4a‐diaza‐s‐indacene (BODIPY) pendants, were synthesized to achieve mitochondria‐targeted photocytotoxicity. The complexes showed strong absorptions in the range λ=510–540 nm. Complex 1 exhibited intense emission at λ=525 nm in 1 % DMSO/water solution (fluorescence quantum yield of 0.06). Nanosecond transient absorption spectral features indicated an enhanced population of the triplet excited state in di‐iodinated complex 2. The generation of singlet oxygen by complex 2 upon exposure to visible light, as evidenced from experiments with 1,3‐diphenylisobenzofuran, is suitable for photodynamic therapy because of the remarkable photosensitizing ability. The complexes resulted in excellent photocytotoxicity in HaCaT cells (half maximal inhibitory concentration IC50≈3 μm, λ=400–700 nm, light dose=10 J cm−2), but they remained non‐toxic in the dark (IC50>100 μm). Confocal microscopy images of 1 and Pt estimation from isolated mitochondria showed colocalization of the complexes in the mitochondria. Complex 2 displayed generation of reactive oxygen species induced by visible light, disruption of the mitochondrial membrane potential, and apoptosis.